I believe that the appointment of the Saint and Julians exit marks a USA centric business. AHZ needs the pericordium aussie material for the adapt business. The Saint will be the new CEO if he proves himself. He did all his training in the USA and is obviously wishing to relocate there.I have no issue with that. He has so much else to offer than Julian commercially for the same salary so we are ahead and he is locating to where the action is. Also he knows Europe which is where the next footprint is with their ageing population and health spend. A good appointment. Just get those sales increasing exponentially.
I believe that the appointment of the Saint and Julians exit...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |